N-(3-(trifluoromethoxy)phenyl) benzamide

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-(3-(trifluoromethoxy)phenyl) benzamide
• 英文别名: N-[3-(trifluoromethoxy)phenyl]benzamide
• 化学式: C₁₄H₁₀F₃NO₂
• 分子量: 281.234
• InChiKey: QXHGJXKORCICSO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  38.3
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  二苯基二硒醚 、 N-(3-(trifluoromethoxy)phenyl) benzamide 在 copper(II) bis(trifluoromethanesulfonate) 作用下， 以 1,2-二氯乙烷 为溶剂， 以82 %的产率得到N–(4–(phenylselanyl)–3–(trifluoromethoxy)phenyl)benzamide
  参考文献：
  名称：

  Copper-Catalyzed Regioselective Remote C–H Bond Chalcogenation of Aromatic Amine Derivatives without Using Any Large Template

  摘要：

  DOI：

  10.1021/acs.orglett.2c04261
• 作为产物：
  描述：

  C₁₄H₉BrF₃NO₂ 在 copper acetylacetonate 、 乙醇 、 二乙胺 、 vasicine 作用下， 反应 12.0h， 以87%的产率得到N-(3-(trifluoromethoxy)phenyl) benzamide
  参考文献：
  名称：

  Exploration of Cu-catalyzed regioselective hydrodehalogenation of o-haloanilides using EtOH as hydrogen source

  摘要：

  DOI：

  10.1016/j.jorganchem.2021.121844

文献信息

• Chromium-Catalyzed Activation of Acyl C–O Bonds with Magnesium for Amidation of Esters with Nitroarenes
  作者：Liang Ling、Changpeng Chen、Meiming Luo、Xiaoming Zeng

  DOI：10.1021/acs.orglett.9b00554

  日期：2019.3.15

  chromium-catalyzed activation of acyl C–O bonds with magnesium for amidation of esters with nitroarenes. Low-cost chromium(III) chloride shows high reactivity in promoting amidation by using magnesium as reductant and chlorotrimethylsilane as additive. It provides a step-economic strategy to the synthesis of centrally important amide motifs using inexpensive and air-stable nitroarenes as amino sources.

  在这里，我们报道了铬与镁催化的羰基C–O键活化，从而使酯与硝基芳烃酰胺化。通过使用镁作为还原剂和氯代三甲基硅烷作为添加剂，低成本的氯化铬（III）在促进酰胺化方面显示出高反应活性。它为使用廉价且空气稳定的硝基芳烃作为氨基源合成重要的酰胺基序提供了分步经济策略。
• [EN] N-ARYL(THIO)ANTHRANILIC ACID AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS VEGF RECEPTOR TYROSINE KINASE INHIBITORS<br/>[FR] DERIVES DE N-ARYL(THIO)ANTHRANILIQUE ACIDE AMIDE, LEUR PREPARATION ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE LA TYROSINE KINASE DU RECEPTEUR VEGF
  申请人：NOVARTIS AG

  公开号：WO2000027820A1

  公开（公告）日：2000-05-18

  Described are compounds of formula (I), wherein W is O or S; X is NR8; Y is CR9R10-(CH2)n wherein R9 and R10 are independently of each other hydrogen or lower alkyl, and n is an integer of from and including 0 to and including 3; or Y is SO2; R1 is aryl; R2 is a mono- or bicyclic heteroaryl group comprising one or more ring nitrogen atoms with the exception that R2 cannot represent 2-phthalimidyl, and in case of Y = SO2 cannot represent 2,1,3-benzothiadiazol-4-yl; any of R3, R4, R5 and R6, independently of the other, is H or a substituent other than hydrogen; and R7 and R8, independently of each other, are H or lower alkyl; or a N-oxide or a pharmaceutically acceptable salt thereof for the preparation of a pharmaceutical product for the treatment of a neoplastic disease which responds to an inhibition of the VEGF receptor tyrosine kinase activity. The compounds of formula (I) can be used for the treatment e.g. of a neoplastic disease, such as a tumor disease, of retinopathy and age-related macular degeneration.

  本文描述了式(I)的化合物，其中W是O或S；X是NR8；Y是CR9R10-(CH2)n，其中R9和R10独立地是氢或低级烷基，n是0至3的整数；或者Y是SO2；R1是芳基；R2是一个含有一个或多个环氮原子的单环或双环杂环基团，但R2不能代表2-苯甲酰亚胺基，且在Y = SO2的情况下不能代表2,1,3-苯并噻二唑-4-基；R3、R4、R5和R6中的任何一个，除了氢之外，都是取代基；R7和R8独立地是氢或低级烷基；或其N-氧化物或药学上可接受的盐，用于制备用于治疗对VEGF受体酪氨酸激酶活性抑制有反应的肿瘤疾病的制药产品。式(I)的化合物可用于治疗肿瘤疾病、视网膜病变和年龄相关性黄斑变性等疾病。
• Reductive transamidation of tertiary amides with nitroarenes enabled by magnesium and chlorosilane
  作者：Shangru Yang、Haohao Zeng、Meiming Luo、Xiaoming Zeng

  DOI：10.1039/d3ob01728a

  日期：——

  Reported here is the reductive transamidation of tertiary amides with nitroarenes promoted by main group metal magnesium and chlorosilane. The reaction uses commercially available and air-stable nitroarenes as nitrogen sources, so it can occur under transition-metal- and ligand-free conditions, thus providing a step-economic and cost-effective strategy for forming centrally important secondary amides

  这里报道的是在主族金属镁和氯硅烷促进下叔酰胺与硝基芳烃的还原转酰胺基化反应。该反应使用市售且空气稳定的硝基芳烃作为氮源，因此可以在无过渡金属和配体的条件下发生，从而为形成重要的仲酰胺提供了一步经济且具有成本效益的策略。通过镁促进的还原性转酰胺基化可以很容易地获得一些生物学上有趣的酰胺基序。
• N-ARYL(THIO)ANTHRANILIC ACID AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS VEGF RECEPTOR TYROSINE KINASE INHIBITORS
  申请人：Novartis AG

  公开号：EP1129075A1

  公开（公告）日：2001-09-05
• COMBINATIONS OF A VEGF RECEPTOR INHIBITOR WITH OTHER THERAPEUTIC AGENTS
  申请人：Novartis AG

  公开号：EP1667721A2

  公开（公告）日：2006-06-14